Related Experiment Video
Updated: Jan 2, 2026

08:37
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
10.2K
PDIA4: The basic characteristics, functions and its potential connection with cancer.
Zeyu Wang1, Hao Zhang1, Quan Cheng2
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410008, PR China.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|December 4, 2019
Summary
Protein disulfide isomerase A4 (PDIA4) links endoplasmic reticulum stress and platelet activation to tumor progression. Inhibiting PDIA4 may offer a novel cancer therapy strategy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Disulfide bond formation, crucial for protein folding, is catalyzed by protein disulfide isomerases (PDIs) in the endoplasmic reticulum.
- PDIA4, a PDI family member, influences platelet activation and thrombosis by modulating αIIβ3 integrin affinity.
- Accumulation of misfolded proteins triggers endoplasmic reticulum stress (ERS), often accompanied by elevated PDIA4 expression.
Purpose of the Study:
- To review the fundamental characteristics of PDIA4.
- To explore the role of PDIA4 in tumor progression.
- To evaluate the potential of PDI inhibitors as anticancer therapeutics.
Main Methods:
- Literature review of PDIA4.
- Analysis of PDIA4's involvement in platelet activation and ERS.
- Examination of PDIA4's impact on tumor cell apoptosis and DNA repair.
Main Results:
- PDIA4 activation of platelets and ERS response are linked to tumor progression.
- PDIA4 influences tumor progression through effects on apoptosis and DNA repair, though mechanisms remain unclear.
- PDIA4 expression increases with ERS, suggesting a role in cellular stress responses.
Conclusions:
- PDIA4 plays a multifaceted role in linking cellular stress and platelet function to cancer development.
- Targeting PDIA4, potentially via PDI inhibitors, represents a promising therapeutic avenue for cancer treatment.
- Further research is needed to elucidate the specific molecular mechanisms by which PDIA4 contributes to tumor progression.
Related Concept Videos
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer Cell Migration through Invadopodia
3.1K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Phosphoinositides and PIPs
10.0K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.0K

